In conclusion, we have estimated the burden of PGVs in established BC risk genes in BRCA1/BRCA2/PALB2-negative CBC cases compared with UBC controls, and found an increased aggregated burden of PGVs in established BC-risk genes, which was modified by age. This evidence concerns the gene BRCA2 and breast cancer.